Back
Olympic Steel 10K Form
Buy
52
ZEUS
Olympic Steel
Last Price:
41.87
Seasonality Move:
14.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-11-03 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-08-04 | 10Q | ZEUS/Olympic Steel Quarterly |
2023-05-05 | 10Q | ZEUS/Olympic Steel Quarterly |
2022-11-04 | 10Q | ZEUS/Olympic Steel Quarterly |
2022-08-05 | 10Q | ZEUS/Olympic Steel Quarterly |
Receive ZEUS News And Ratings
See the #1 stock for the next 7 days that we like better than ZEUS
ZEUS Financial Statistics
Sales & Book Value
Annual Sales: | $2.16B |
---|---|
Cash Flow: | $15.56M |
Price / Cash Flow: | 9.98 |
Annual Sales: | $51.26 |
Price / Book: | 0.82 |
Profitability
EPS (TTM): | 2.28000 |
---|---|
Net Income (TTM): | $26.5M |
Gross Margin: | $473.5M |
Return on Equity: | 4.72% |
Return on Assets: | 2.65% |
Olympic Steel Earnings Forecast
Key Olympic Steel Financial Ratios
- The Gross Profit Margin over the past 30 years for ZEUS is 21.94%.
- The Selling, General & Administrative Expenses for ZEUS have been equal to 11.45% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 35.95% of Operating Income.
- The Net Earning history of ZEUS is 2.06% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 15 years.
Olympic Steel Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | ZEUS |
CUSIP: | 68162K |
Website: | olysteel.com |
Debt
Debt-to-Equity Ratio: | 0.35 |
---|---|
Current Ratio: | 3.52 |
Quick Ratio: | 1.18 |
Price-to-Earnings
Trailing P/E Ratio: | 10.94 |
---|---|
Forward P/E Ratio: | 13.95 |
ZEUS Technical Analysis vs Fundamental Analysis
Buy
52
Olympic Steel (ZEUS)
is a Buy
Is Olympic Steel a Buy or a Sell?
-
Olympic Steel stock is rated a Buy
The current Olympic Steel [ZEUS] share price is $41.74. The Score for ZEUS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.